Part B News | Inflation Reduction Act Caps Insulin Costs, Grants CMS Drug Negotiating Power | News & Insights

Health Care Week in Review November 10, 2023

Health Care Week In Review: Senate Finance Committee Advanced Bipartisan Healthcare Legislation, CMS Released Medicare Advantage and Part D Proposed Rule

This week, the Senate Finance Committee advanced the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act to expand mental health care and lower prescription drug costs for seniors, and CMS released the Contract Year 2025 Medicare Advantage (MA) and Part D Proposed Rule.

Health Care Week in Review August 12, 2022

Health Care Week in Review: Congress Considers the Inflation Reduction Act of 2022

This week, Congress is expected to pass the Inflation Reduction Act of 2022, which includes numerous health-related provisions such as prescription drug inflation rebates; out-of-pocket caps for Medicare Part D; and drug price negotiation.

Health Care Week in Review June 7, 2019

Alston & Bird Health Care Week in Review, June 7, 2019

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.

Health Care Week in Review May 31, 2019

Alston & Bird Healthcare Week in Review, May 31, 2019

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health policy news.

Healthy Byte July 24, 2024

Healthy Byte: Provider Disincentives Rule for Information Blocking

Tania Khan and Elinor Hiller discuss the new disincentives established for Medicare-enrolled providers or suppliers that have committed “information blocking.”